References
Haller JA, Kuppermann BD, Blumenkranz MS, Williams GA, Weinberg DV, Chou C, Whitcup SM (2010) Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema. Arch Opthalmol 128:289–296
Williams GA, Haller JA, Kuppermann BD, Blumenkranz MS, Weinberg DV, Chou C, Whitcup SM (2009) Dexametashone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine–Gass syndrome. Am J Ophthalmol 147:1048–1054
Ruiz-Moreno JM, Montero JA, Artola A, Barile S (2005) Anterior chamber transit of triamcinolone after intravitreal injection. Arch Ophthalmol 123:129–130
Moshfeghi AA, Scott IU, Flynn HW Jr, Puliafito CA (2004) Pseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema. Am J Ophthalmol 138:489–492
Financial interest
The authors have no financial interest to disclose.
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors certify that they have not been published or are being considered for publication elsewhere. The authors also transfer property rights (copyright) of this work to Graefe’s Archive for Clinical and Experimental Opthalmology.
Rights and permissions
About this article
Cite this article
Pardo-López, D., Francés-Muñoz, E., Gallego-Pinazo, R. et al. Anterior chamber migration of dexametasone intravitreal implant (Ozurdex®). Graefes Arch Clin Exp Ophthalmol 250, 1703–1704 (2012). https://doi.org/10.1007/s00417-011-1802-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-011-1802-x